No takes yet. Share an insight, caveat, or question.
Review highlights bioprinting technology and high-throughput screening in cardiac research, suggesting novel therapeutics improve disease modeling and toxicity testing.
Nguyen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: